John F Crowley - Net Worth and Insider Trading
John F Crowley Net Worth
The estimated net worth of John F Crowley is at least $7 Million dollars as of 2024-04-25. John F Crowley is the Executive Chairman of Amicus Therapeutics Inc and owns about 638,373 shares of Amicus Therapeutics Inc (FOLD) stock worth over $6 Million. John F Crowley is the Director of Entrada Therapeutics Inc and owns about 37,864 shares of Entrada Therapeutics Inc (TRDA) stock worth over $456,640. John F Crowley is also the Director of Intellia Therapeutics Inc and owns about 2,094 shares of Intellia Therapeutics Inc (NTLA) stock worth over $41,482. Details can be seen in John F Crowley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John F Crowley has not made any transactions after 2024-03-01 and currently still holds the listed stock(s).
Transaction Summary of John F Crowley
John F Crowley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John F Crowley owns 3 companies in total, including Intellia Therapeutics Inc () , Amicus Therapeutics Inc () , and Entrada Therapeutics Inc () .
Click here to see the complete history of John F Crowley’s form 4 insider trades.
Insider Ownership Summary of John F Crowley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Intellia Therapeutics Inc | 2021-10-11 | director | |
| Amicus Therapeutics Inc | 2024-03-01 | director & Executive Chairman | |
| Entrada Therapeutics Inc | 2022-01-12 | director |
John F Crowley Latest Holdings Summary
John F Crowley currently owns a total of 3 stocks. Among these stocks, John F Crowley owns 638,373 shares of Amicus Therapeutics Inc (FOLD) as of March 1, 2024, with a value of $6 Million and a weighting of 92.84%. John F Crowley owns 37,864 shares of Entrada Therapeutics Inc (TRDA) as of January 12, 2022, with a value of $456,640 and a weighting of 6.56%. John F Crowley also owns 2,094 shares of Intellia Therapeutics Inc (NTLA) as of October 11, 2021, with a value of $41,482 and a weighting of 0.6%.
Latest Holdings of John F Crowley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2024-03-01 | 638,373 | 10.12 | 6,460,335 |
| TRDA | Entrada Therapeutics Inc | 2022-01-12 | 37,864 | 12.06 | 456,640 |
| NTLA | Intellia Therapeutics Inc | 2021-10-11 | 2,094 | 19.81 | 41,482 |
Holding Weightings of John F Crowley
John F Crowley Form 4 Trading Tracker
According to the SEC Form 4 filings, John F Crowley has made a total of 101 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 101 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 29,181 shares on March 1, 2024, which brought John F Crowley around $389,566.
According to the SEC Form 4 filings, John F Crowley has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 5,000 shares on January 12, 2022, which cost John F Crowley around $48,600.
According to the SEC Form 4 filings, John F Crowley has made a total of 2 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 2,500 shares on October 11, 2021, which brought John F Crowley around $298,875.
Insider Trading History of John F Crowley
- 1
John F Crowley Trading Performance
GuruFocus tracks the stock performance after each of John F Crowley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Crowley is -19.7%. GuruFocus also compares John F Crowley's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Crowley within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John F Crowley's insider trading performs compared to the benchmark.
Performance of John F Crowley
Average Return
23.06%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.38 | -19.7 | 5.02 | 23.06 | -3.14 | -8 |
| Relative Return to S&P 500(%) | 3.72 | -20.11 | 5.99 | 14.42 | -13.96 | -21.45 |
John F Crowley Ownership Network
Ownership Network List of John F Crowley
Ownership Network Relation of John F Crowley
John F Crowley Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
John F Crowley is the director of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and EVP & Chief Medical Officer David Lebwohl .
Intellia Therapeutics Inc () Insider Trades Summary
Over the past 18 months, John F Crowley made no insider transaction in Intellia Therapeutics Inc (). Other recent insider transactions involving Intellia Therapeutics Inc () include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .
In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.
Intellia Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
John F Crowley Mailing Address
Above is the net worth, insider trading, and ownership report for John F Crowley. You might contact John F Crowley via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
